A novel regulator of breast development
乳房发育的新型调节剂
基本信息
- 批准号:8764122
- 负责人:
- 金额:$ 19.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-11 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:8p22AdultAffectBone DevelopmentBreastBreast Cancer PreventionBreast DiseasesBreast FeedingCandidate Disease GeneCenters for Disease Control and Prevention (U.S.)ChildChromosomesCongenital AbnormalityCustomDNADefectDevelopmentDiseaseEmbryoEndocrineEngineeringEpithelialExhibitsExogenous FactorsExploratory/Developmental GrantExtended FamilyFamilyFamily memberFemaleFundingFutureGene MutationGenesGenomeGoalsHairHormonesHumanHuman DevelopmentInfantInheritance PatternsInheritedInterventionIntrinsic factorKnock-in MouseLactationLibrariesMalignant NeoplasmsMammalsMammary Gland ParenchymaMammary glandMapsMental HealthMesenchymalMesenchymeMethodsMilkModelingMolecularMorphogenesisMothersMusMutationNatureNipplesPathway interactionsPatternPhenotypePopulationPostpartum PeriodProductionPropertyResearchResourcesSingle Nucleotide Polymorphism MapSyndromeTechnologyTissue-Specific Gene ExpressionTissuesTooth structureTumor SubtypeUnited StatesWomanWorkappendageautosomal dominant traitbasecancer initiationcancer riskdeep sequencingimprovedmalemalignant breast neoplasmmammary epitheliummammary gland developmentmenmouse genomemouse modelnovelpublic health relevancestatisticsstemtooltraittumor progressionzinc finger nuclease
项目摘要
DESCRIPTION (provided by applicant): Mammary gland development is essential for the viability of most mammals and the sustainability of many human populations. In addition, exogenous and intrinsic factors that control mammary morphogenesis have repeatedly been implicated in regulating breast cancer risk, tumor subtype, and/or metastatic progression. Thus, identifying the networks that control mammary morphogenesis is necessary for sustaining human development and discovering additional contributors to breast disease. We have recently identified a novel extended family with a breast developmental defect. Half of all males and females in this family have congenital nipple dysmorphia and females fail to develop breasts. The trait follows an autosomal dominant inheritance pattern, does not correspond to any previously described breast developmental defect, and has been mapped to a single chromosomal region that does not contain any established breast development genes. Thus, this family provides a unique opportunity to discover a novel mutation/gene that controls breast development and potentially cancer. With this proposal, deep sequencing will be performed on affected and unaffected family members to identify the specific mutation in this family that segregates with the amastia phenotype. The tissue specific expression of this gene will then be assessed throughout normal mammary gland development in the mouse and in adult human breast tissue. Lastly, we will develop a novel genetically- manipulated mouse model wherein the human mutation has been engineered in the mouse genome. These mice will be a vital resource for establishing the function of the identified gene in breast development and the impact of the human mutation on that function. Upon completion, this R21 proposal will uncover a completely new pathway controlling breast morphogenesis and generate necessary tools for future analyses of the mechanism(s) by which it controls development and possibly cancer.
描述(由申请人提供):乳腺发育对大多数哺乳动物的生存能力和许多人类种群的可持续性至关重要。此外,控制乳腺形态发生的外源性和内源性因素反复参与调节乳腺癌的风险、肿瘤亚型和/或转移进展。因此,确定控制乳腺形态发生的网络对于维持人类发育和发现导致乳腺疾病的其他因素是必要的。我们最近发现了一个具有乳房发育缺陷的新大家庭。在这个家族中,一半的男性和女性都有先天性乳头畸形,女性无法发育乳房。该性状遵循常染色体显性遗传模式,不符合任何先前描述的乳房发育缺陷,并且已被定位到不包含任何已建立的乳房发育基因的单个染色体区域。因此,这个家族为发现控制乳房发育和潜在癌症的新突变/基因提供了一个独特的机会。根据这一建议,将对受影响和未受影响的家庭成员进行深度测序,以确定该家庭中与无胸型分离的特定突变。该基因的组织特异性表达将在小鼠和成人乳腺组织的正常乳腺发育过程中进行评估。最后,我们将开发一种新的基因操纵小鼠模型,其中人类突变已经在小鼠基因组中进行了工程设计。这些小鼠将成为确定已鉴定基因在乳房发育中的功能以及人类突变对该功能的影响的重要资源。一旦完成,这项R21提案将揭示控制乳房形态发生的全新途径,并为未来分析其控制发育和可能的癌症的机制提供必要的工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH A. KERI其他文献
RUTH A. KERI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH A. KERI', 18)}}的其他基金
Discovering the role of YES1 in triple negative breast cancer
发现 YES1 在三阴性乳腺癌中的作用
- 批准号:
10550218 - 财政年份:2021
- 资助金额:
$ 19.81万 - 项目类别:
Discovering the role of YES1 in triple negative breast cancer
发现 YES1 在三阴性乳腺癌中的作用
- 批准号:
10746980 - 财政年份:2021
- 资助金额:
$ 19.81万 - 项目类别:
Discovering the role of YES1 in triple negative breast cancer
发现 YES1 在三阴性乳腺癌中的作用
- 批准号:
10154539 - 财政年份:2021
- 资助金额:
$ 19.81万 - 项目类别:
Targeting BET proteins in Triple Negative Breast Cancer
靶向三阴性乳腺癌中的 BET 蛋白
- 批准号:
10265806 - 财政年份:2020
- 资助金额:
$ 19.81万 - 项目类别:
Elucidating and Leveraging the mTOR Negative Feedback Pathway in Breast Cancer
阐明和利用乳腺癌中的 mTOR 负反馈通路
- 批准号:
10225343 - 财政年份:2017
- 资助金额:
$ 19.81万 - 项目类别:
Elucidating and Leveraging the mTOR Negative Feedback Pathway in Breast Cancer
阐明和利用乳腺癌中的 mTOR 负反馈通路
- 批准号:
10278978 - 财政年份:2017
- 资助金额:
$ 19.81万 - 项目类别:
Targeting BET proteins in Triple Negative Breast Cancer
靶向三阴性乳腺癌中的 BET 蛋白
- 批准号:
9127467 - 财政年份:2016
- 资助金额:
$ 19.81万 - 项目类别:
KLF4 regulation of epithelial/mesenchymal transition in breast cancer
KLF4对乳腺癌上皮/间质转化的调节
- 批准号:
8114768 - 财政年份:2011
- 资助金额:
$ 19.81万 - 项目类别:
KLF4 regulation of epithelial/mesenchymal transition in breast cancer
KLF4对乳腺癌上皮/间质转化的调节
- 批准号:
8465136 - 财政年份:2011
- 资助金额:
$ 19.81万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 19.81万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 19.81万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 19.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 19.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 19.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)